Skip to main content
. 2019 Sep 9;25:1076029619872550. doi: 10.1177/1076029619872550

Table 3.

Risk Factors According to Thrombosis Site.

Risk Factor CVT, n = 25 JVT, n = 16 UEDVT, n = 33 AVT, n = 33 P
Cancer, n (%) 6 (24.0%) 9 (56.2%) 7 (21.2%) 25 (75.7%) <.01
 Solid cancer, n (%) 3 (12.0%) 8 (50.0%) 6 (18.2%) 19 (57.6%)
 Hematological cancer, n (%) 3 (12.0%) 1 (6.2%) 1 (3.0%) 6 (18.1%)
 −JAK2+ MPN, n (%) 3 (12.0%) 0 (0.0%) 0 (0.0%) 4 (12.1%)
Oral contraceptives, n/number of women (%) 5/18 (27.7%) 0/8, (0.0%) 0/17, (0.0%) 0/11, (0.0%)
CVC, n (%) 0 (0.0%) 0 (0.0%) 16 (48.4%) 0 (0.0%)
PM, n (%) 0 (0.0%) 0 (0.0%) 2 (1.8%) 0 (0.0%)
Thoracic outlet syndrome, n (%) 0 (0.0%) 0 (0.0%) 6 (18.1%) 0 (0.0%)
Liver cirrhosis, n (%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 5 (15.1%)
Trauma, n (%) 0 (0.0%) 1 (6.2%) 0 (0.0%) 0 (0.0%)
Sepsis, n (%) 0 (0.0%) 1 (6.2%) 0 (0.0%) 0 (0.0%)
DIC, n (%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (3.0%)
Pancreatitis, n (%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (3.0%)
Surgery, n (%) 1 (4.0%) 0 (0.0%) 0 (0.0%) 1 (3.0%)
None of the above-listed risk factors 13 (52.0%) 5 (31.2%) 2 (6.1%) 0 (0.0%) <.0001

Abbreviations: AVT, abdominal vein thrombosis; CVC, central venous catheter; CVT, cerebral vein thrombosis; DIC, disseminated intravascular coagulation; JVT, jugular vein thrombosis; MPN, myeloproliferative neoplasm; PM, pacemaker; UEDVT, upper extremities deep vein thrombosis.